Cisplatin/Gemcitabine/Pembrolizumab Regimen

Preferred Label : Cisplatin/Gemcitabine/Pembrolizumab Regimen;

Obsolete resource : false;

NCIt synonyms : Cisplatin/Gemcitabine/Pembrolizumab; Cisplatin/Gemcitabine/Keytruda; Cisplatin-Gemcitabine-Pembrolizumab;

NCIt related terms : Cisplatin and Gemcitabine (GC) and Pembrolizumab;

NCIt definition : A regimen composed of cisplatin, gemcitabine, and pembrolizumab that may be used in the treatment of non-small cell lung cancer (NSCLC), biliary tract cancer and cancer of the nasopharynx.;

NCI Metathesaurus CUI : CL1926255;

Codes from synonyms : 60461;

Details

Origin ID

C203955;

UMLS CUI

C5909519;

Est indiqué pour
- Locally Advanced Bile Duct Carcinoma [NCIt concept]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Cisplatin [NCIt concept]
- Gemcitabine Hydrochloride [NCIt concept]
- Pembrolizumab [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients